B6;129P2-Ctsdtm1Cptr/Ph

Status

Available to order

EMMA IDEM:08122
International strain nameB6;129P2-Ctsdtm1Cptr/Ph
Alternative nameCathepsin D
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolCtsdtm1Cptr
Gene/Transgene symbolCtsd

Information from provider

ProviderPaul Saftig
Provider affiliationInstitute of Biochemistry, Christian-Albrechts-University Kiel
Genetic informationA 9.6 kb restriction fragment of cosmid clone mCDI was subcloned. The neo expression cassette from pMCIneopA was inserted into a KpnI restriction site in exon 4 of the Ctsd gene. A linker fragment had been ligated to the XhoI site at the 5' end of the neo cassette and a second linker fragment had been ligated to the HindlIl site at the 3' end of the neo cassette. The insertion of the neo cassette introduces a premature translational stop codon into the ORF of the Ctsd gene. The recombination construct (pCDneo4) was linearized with Notl and introduced into the ES cell line E14.1.
Phenotypic informationHomozygous:
During first 2 weeks of life no phenotypic differences are detectable between homozygous Ctsd -/- mice and wild-type littermates. Thereafter weight increase of the Ctsd -/- animals begins to stagnate and weight starts to decline. At day 25, the mean weight of the Ctsd -/- mice was only 60% of that of wild-type littermates. Homozygous mutant animals die between day 25 and 27. During last days of life, Ctsd -/- animals exhibit reduction of spontaneous locomotion and escape reactions; progressive atactic gait disturbance was also observed. Necrosis of the small intestine was seen on autopsy of affected animals.

Heterozygous:
Heterozygous mice appear normal like wild-type mice.
References
  • Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells.;Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, Köster A, Hess B, Evers M, von Figura K, ;1995;The EMBO journal;14;3599-608; 7641679
  • Accumulation of bis(monoacylglycero)phosphate and gangliosides in mouse models of neuronal ceroid lipofuscinosis.;Jabs Sabrina, Quitsch Arne, Käkelä Reijo, Koch Bettina, Tyynelä Jaana, Brade Helmut, Glatzel Markus, Walkley Steven, Saftig Paul, Vanier Marie T, Braulke Thomas, ;2008;Journal of neurochemistry;106;1415-25; 18498441
Homozygous fertileno
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreInstitute of Molecular Genetics, Prague, Czech Republic

Disease and phenotype information

MGI allele-associated human disease models

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • increased circulating aspartate transaminase level / IMPC
  • corneal opacity / IMPC
  • decreased hematocrit / IMPC
  • preweaning lethality, incomplete penetrance / IMPC
MGI phenotypes (allele matching)
  • abnormal microglial cell morphology / MGI
  • abnormal crypts of Lieberkuhn morphology / MGI
  • abnormal intestinal mucosa morphology / MGI
  • decreased body weight / MGI
  • abnormal retina morphology / MGI
  • ataxia / MGI
  • abnormal apoptosis / MGI
  • thymus hypoplasia / MGI
  • abnormal antigen presentation / MGI
  • blindness / MGI
  • seizures / MGI
  • premature death / MGI
  • abnormal spleen white pulp morphology / MGI
  • abnormal ileum morphology / MGI
  • tonic seizures / MGI
  • decreased lymphocyte cell number / MGI
  • abnormal thrombosis / MGI
  • lysosomal protein accumulation / MGI
  • decreased double-positive T cell number / MGI
  • bradykinesia / MGI
  • cellular phenotype / MGI
  • retinal photoreceptor degeneration / MGI
  • abnormal spleen B cell follicle morphology / MGI
MGI phenotypes (gene matching)
  • abnormal microglial cell morphology / MGI
  • abnormal hair cycle / MGI
  • abnormal crypts of Lieberkuhn morphology / MGI
  • abnormal intestinal mucosa morphology / MGI
  • weakness / MGI
  • hippocampal neuron degeneration / MGI
  • decreased body weight / MGI
  • abnormal retina morphology / MGI
  • ataxia / MGI
  • abnormal apoptosis / MGI
  • thymus hypoplasia / MGI
  • abnormal antigen presentation / MGI
  • deafness / MGI
  • blindness / MGI
  • seizures / MGI
  • premature death / MGI
  • abnormal spleen white pulp morphology / MGI
  • abnormal ileum morphology / MGI
  • tonic seizures / MGI
  • abnormal cochlear ganglion morphology / MGI
  • neuron degeneration / MGI
  • axonal dystrophy / MGI
  • thymus atrophy / MGI
  • decreased lymphocyte cell number / MGI
  • abnormal thrombosis / MGI
  • lysosomal protein accumulation / MGI
  • decreased double-positive T cell number / MGI
  • cachexia / MGI
  • bradykinesia / MGI
  • cellular phenotype / MGI
  • retinal photoreceptor degeneration / MGI
  • abnormal spleen B cell follicle morphology / MGI
  • abnormal stomach wall morphology / MGI
  • lethality at weaning, complete penetrance / MGI
  • prenatal lethality, incomplete penetrance / MGI
  • preweaning lethality, incomplete penetrance / MGI
  • increased or absent threshold for auditory brainstem response / MGI

Literature references

  • Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells.;Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, Köster A, Hess B, Evers M, von Figura K, ;1995;The EMBO journal;14;3599-608; 7641679
  • Accumulation of bis(monoacylglycero)phosphate and gangliosides in mouse models of neuronal ceroid lipofuscinosis.;Jabs Sabrina, Quitsch Arne, Käkelä Reijo, Koch Bettina, Tyynelä Jaana, Brade Helmut, Glatzel Markus, Walkley Steven, Saftig Paul, Vanier Marie T, Braulke Thomas, ;2008;Journal of neurochemistry;106;1415-25; 18498441

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).